Schering-Plough Corporation

Schering-Plough Corporation (United States) holds 0 active US FDA Type II Drug Master Files and 1 inactive. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Schering-Plough Corporation: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/schering-plough-corporation

Overview

Schering-Plough Corporation was a global pharmaceutical company known for its research and development activities in various therapeutic areas. It became a subsidiary of Merck & Co., Inc. in 2009 following a merger, expanding Merck's portfolio in several therapeutic areas.

Therapeutic areas

API / Drug Master Files

Schering-Plough Corporation holds 0 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES.Inactive1982-05-25

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Schering-Plough Corporation in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Schering-Plough Corporation?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.